142 related articles for article (PubMed ID: 8128430)
1. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies.
Green D; Rademaker AW; Briët E
Thromb Haemost; 1993 Nov; 70(5):753-7. PubMed ID: 8128430
[TBL] [Abstract][Full Text] [Related]
2. [Combined treatment with factor VIII and immunosuppressive agents in a young woman with acquired factor VIII inhibitor].
José Aguado M; Carrasco V; Periago A; Bello T; González E; García-Talavera J
Sangre (Barc); 1996 Apr; 41(2):147-50. PubMed ID: 9045356
[TBL] [Abstract][Full Text] [Related]
3. A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine.
Hart HC; Kraaijenhagen RJ; Kerckhaert JA; Verdel G; Freen M; van de Wiel A
Transplant Proc; 1988 Jun; 20(3 Suppl 4):323-8. PubMed ID: 3132776
[TBL] [Abstract][Full Text] [Related]
4. New protocol for immune tolerance induction in acquired hemophilia.
Nemes L; Pitlik E
Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
[TBL] [Abstract][Full Text] [Related]
5. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases.
Huang YW; Saidi P; Philipp C
Haemophilia; 2004 Nov; 10(6):713-21. PubMed ID: 15569166
[TBL] [Abstract][Full Text] [Related]
6. [Immunosuppressive treatment of a spontaneous inhibitor hemophilia A using cyclophosphamide, vincristine and prednisone following prior Factor VIII stimulation].
Dürig J; de Wit M; Fiedler W; Marx G; Hossfeld DK
Schweiz Med Wochenschr; 1996 Nov; 126(47):2026-31. PubMed ID: 8984611
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII antibodies in rheumatoid arthritis. Effect of cyclophosphamide.
Green D; Schuette PT; Wallace WH
Arch Intern Med; 1980 Sep; 140(9):1232-5. PubMed ID: 6773487
[TBL] [Abstract][Full Text] [Related]
8. [Acquired factor VIII inhibitor in a patient with rheumatoid arthritis].
Ruiz-Calderón AJ; Carrasco F; Duro R; Constantino M
Sangre (Barc); 1993 Oct; 38(5):403-5. PubMed ID: 8140505
[TBL] [Abstract][Full Text] [Related]
9. [Long-term response to rituximab in a patient with acquired hemophilia].
García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A
Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725
[TBL] [Abstract][Full Text] [Related]
10. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy.
Field JJ; Fenske TS; Blinder MA
Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724
[TBL] [Abstract][Full Text] [Related]
11. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
Hertzberg MS; Favaloro E; Koutts J
Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
[No Abstract] [Full Text] [Related]
12. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome.
Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M
Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337
[TBL] [Abstract][Full Text] [Related]
13. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
[TBL] [Abstract][Full Text] [Related]
14. The management of factor VIII inhibitors in non-hemophilic patients.
Green D
Prog Clin Biol Res; 1984; 150():337-52. PubMed ID: 6431438
[TBL] [Abstract][Full Text] [Related]
15. Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone.
Lian EC; Villar MJ; Noy LI; Ruiz-Dayao Z
Am J Hematol; 2002 Apr; 69(4):294-5. PubMed ID: 11921026
[TBL] [Abstract][Full Text] [Related]
16. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
17. [Fatal opportunistic infection following disappearance of antibodies by immunosuppressive therapy in a patient with acquired factor VIII inhibitor].
Kubota Y; Sano M; Nakazato S; Tsuneyoshi N; Tomimasu R; Kuwahara N; Fukushima N; Funai N; Suga K; Sueoka E
Rinsho Ketsueki; 2004 Sep; 45(9):1023-7. PubMed ID: 15510829
[TBL] [Abstract][Full Text] [Related]
18. Randomized comparison of cladribine alone or in combination with cyclophosphamide, and cyclophosphamide, vincristine and prednisone in previously untreated low-grade B-cell non-Hodgkin lymphoma patients: final report of the Polish Lymphoma Research Group.
Kalinka-Warzocha E; Wajs J; Lech-Maranda E; Ceglarek B; Holowiecki J; Federowicz I; Walewski J; Czyz J; Robak T; Warzocha K;
Cancer; 2008 Jul; 113(2):367-75. PubMed ID: 18470902
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
Petrovic M; Derom E; Baele G
Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
[No Abstract] [Full Text] [Related]
20. Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus.
Schulman S; Langevitz P; Livneh A; Mortinowitz U; Seligsohn U; Varon D
Thromb Haemost; 1996 Sep; 76(3):344-6. PubMed ID: 8883268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
